Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

10.46243/jst.2024.v9.i2.pp72-110 registered

Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders

Resolves to https://jst.org.in/index.php/pub/article/view/1460

Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2024.v9.i2.pp72-110

Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 1042706a6655dc1f…

Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)

Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).

What the DOI identifies

JournalArticle — an article in a journal · Digital · Visual · en

Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders (PrincipalTitle · en)

Published 2024-02-02

Part of Journal of Science & Technology · ISSN 2456-5660 · volume 09 · issue 02 · pages 72

Agents

  • B Sandhya Rani (author)
  • I. Triveni (author)
  • B.Revathi (author)
  • N. Danamurthy (author)
  • Longman Publishers (publisher)

Identifiers DOI 10.46243/jst.2024.v9.i2.pp72-110

Abstract · en

The enzymes known as sirtuins, or silent information regulator 2, are histone deacetylases that depend on nicotinamide adenine dinucleotide (NAD+). In addition to its well-established role in prolonging longevity, further study is necessary to examine the beneficial effects of Sirtuin 1 (SIRT1), a member of the sirtuin group, on lipid metabolism. SIRT1 has been extensively associated with the control of gene expression. The SIRT1 substrate sterol regulatory element-binding protein (SREBP) has garnered a lot of attention because of its involvement in a number of biological processes, such as metabolic activities, DNA damage repair, and cell cycle control. Therefore, the aim of this investigation was to examine and clarify the relationship between SIRT1 and SREBPs and evaluate the role of SIRT1/SREBPs in reducing dysfunction in lipid metabolism. Investigating whether SIRT1 and SREBPs may be used as feasible targets for therapeutic intervention in the management of diabetic complications was the aim of this study.

Licence https://creativecommons.org/licenses/by/4.0

System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1

Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.

ElementValueIn the record
DOI Name
DOI name
10.46243/jst.2024.v9.i2.pp72-110doi
Referent Type
referentType
Creationreferent
Referent Sub-Type
referentSubType
JournalArticle — an article in a journaltype
Referent Name(s)
referentName(s)
Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders (PrincipalTitle, en)titles
Basic Metadata
basicMetadata
author: B Sandhya Rani
author: I. Triveni
author: B.Revathi
author: N. Danamurthy
publisher: Longman Publishers
published: 2024-02-02
part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 09 · no. 02 · pp. 72
language: en
form: Digital · Visual · Language
agents, dates, container, language, structural_type, modes, characters
Referent Identifier(s)
alternateIdentifier(s)
none besides the DOIidentifiers, relations (IsSameAs)
Registration Authority
registrationAuthorityCode
Crossref — issued by Crossref (member 25296); held here as a copyrecord.source_agency (our code, ra_doi_name, for names issued here once appointed)
Created Date
issueDate
2026-08-26record.registered (when the DOI name was first registered)
relatedIdentifiersnone needed — the descriptive metadata is in this recordcontainer, relations (only where the descriptive metadata lives at another identifier)

complete Every System Metadata element is here, with the basic metadata a journal article needs.

The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs

Cited by — in this registry

No record held in this registry cites this DOI.

Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON

References with DOIs

The record lists 183 references; 181 carry a DOI.

#ReferenceDOIHeld here
1ref1 P. Agbu, R.W. Carthew, MicroRNA-mediated regulation of glucose and lipid metabolism, Nat. Rev. Mol. Cell Biol. 22 (2021) 425–43810.1038/s41580-021-00354-wnot held here
3ref3 X. Hua, C. Yokoyama, J. Wu, et al., SREBP-2, a second basic-helix-loop-helix- leucine zipper protein that stimulates transcription by binding to a sterol regulatory element, Proc.…10.1073/pnas.90.24.11603not held here
4ref4 X. Wang, R. Sato, M.S. Brown, et al., SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis, Cell 77 (1994) 53–6210.1016/0092-8674(94)90234-8not held here
5ref5 X. Hua, J. Sakai, Y.K. Ho, et al., Hairpin orientation of sterol regulatory element- binding protein-2 in cell membranes as determined by protease protection, J. Biol. Chem. 270 (…10.1074/jbc.270.49.29422not held here
6ref6 A. Vassilopoulos, K.S. Fritz, D.R. Petersen, et al., The human sirtuin family: evolutionary divergences and functions, Hum. Genom. 5 (2011) 485–49610.1186/1479-7364-5-5-485not held here
7ref7 W. Giblin, M.E. Skinner, D.B. Lombard, Sirtuins: guardians of mammalian healthspan, Trends Genet 30 (2014) 271–286J. Min, J. Landry, R. Fau-Sternglanz, R. Sternglanz, R.M. Fau-Xu,…10.1016/j.tig.2014.04.007not held here
8ref8 B.J. North, E. Verdin, Sirtuins: Sir2-Relat. NAD-Depend. Protein deacetylases (2004) 22410.1186/gb-2004-5-5-224not held here
9ref9 E. Seto, M. Yoshida, Erasers of histone acetylation: the histone deacetylase enzymes, Cold Spring Harb. Perspect. Biol. 6 (2014) a01871310.1101/cshperspect.a018713not held here
10ref10 P. Vong, H. Ouled-Haddou, L. Garçon, Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis, Int J. Mol. Sci. 23 (2022)10.3390/ijms23179790not held here
11ref11 V. Kumar, S. Kundu, A. Singh, et al., Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective, Cu…10.2174/1570159x19666210609160017not held here
12ref12 S. Imai, C.M. Armstrong, M. Kaeberlein, et al., Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase, Nature 403 (2000) 795–80010.1038/35001622not held here
13ref13 R.H. Houtkooper, E. Pirinen, J. Auwerx, Sirtuins as regulators of metabolism and healthspan, Nat. Rev. Mol. Cell Biol. 13 (2012) 225–23810.1038/nrm3293not held here
14ref14 R.A. Frye, Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins, Biochem Biophys. Res Commun. 273 (2000) 793–79810.1006/bbrc.2000.3000not held here
15ref15 H. Yuan, R. Marmorstein, Structural basis for sirtuin activity and inhibition, J. Biol. Chem. 287 (2012) 42428–42435V. Carafa, D. Rotili, M. Forgione, et al., Sirtuin functions an…10.1074/jbc.r112.372300not held here
16ref16 Z. Wei, J. Song, G. Wang, et al., Deacetylation of serine hydroxymethyl- transferase 2 by SIRT3 promotes colorectal carcinogenesis, Nat. Commun. 9 (2018), 446810.1038/s41467-018-06812-ynot held here
17ref17 I.C. Chen, W.F. Chiang, S.Y. Liu, et al., Role of SIRT3 in the regulation of redox balance during oral carcinogenesis, Mol. Cancer 12 (2013), 6810.1186/1476-4598-12-68not held here
18ref18 W. Yao, S. Ji, Y. Qin, et al., Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis, Mol. Cancer 13 (2014), 18710.1186/1476-4598-13-187not held here
19ref19 D. Xu, H. He, X. Jiang, et al., SIRT2 plays a novel role on progesterone, estradiol and testosterone synthesis via PPARs/LXRα pathways in bovine ovarian granular cells, J. Steroid…10.1016/j.jsbmb.2018.07.005not held here
20ref20 K.H. Fisher-Wellman, J.A. Draper, M.T. Davidson, et al., Respiratory Phenomics across Multiple Models of Protein Hyperacylation in Cardiac Mitochondria Reveals a Marginal Impact o…10.1016/j.celrep.2019.01.057not held here
21ref21 T. Heinonen, E. Ciarlo, D. Le Roy, et al., Impact of the Dual Deletion of the Mitochondrial Sirtuins SIRT3 and SIRT5 on Anti-microbial Host Defenses, Front Immunol. 10 (2019), 234110.3389/fimmu.2019.02341not held here
22ref22 G. Nowak, J. Megyesi, Protein kinase Cα mediates recovery of renal and mitochondrial functions following acute injury, Febs J. 287 (2020) 1830–1849, M.C. Haigis, R. Mostoslavsky, …10.1111/febs.15110not held here
23ref23 A. Akkulak, G.D. Yalcin, The interaction of SIRT4 and Calreticulin during ER stress in glia cells, Gene 814 (2022), 14613510.1016/j.gene.2021.146135not held here
24ref24 G. Cai, Z. Ge, Y. Xu, et al., SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism, Sci. Rep. 12 (2022), 1220810.1038/s41598-022-16610-8not held here
26ref26 H. Weng, W. Song, K. Fu, et al., Proteomic profiling reveals the potential mechanisms and regulatory targets of sirtuin 4 in 1-methyl-4-phenyl- 1,2,3,6-tet- rahydropyridine-induce…10.3389/fnins.2022.1035444not held here
27ref27 J. Li, H. Zhan, Y. Ren, et al., Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway, Cell Death Differ. 30 (2023) 313–32610.1038/s41418-022-01063-3not held here
28ref28 X. Quan, Y. Xin, H.L. Wang, et al., Implications of altered sirtuins in metabolic regulation and oral cancer, PeerJ 11 (2023), e1475210.7717/peerj.14752not held here
29ref29 M.J. Rardin, W. He, Y. Nishida, et al., SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks, Cell Metab. 18 (2013) 920–93310.1016/j.cmet.2013.11.013not held here
30ref30 T.L. Kawahara, E. Michishita, A.S. Adler, et al., SIRT6 links histone H3 lysine 9 deacetylation to NFkappaB-dependent gene expression and organismal life span, Cell 136 (2009) 62–…10.1016/j.cell.2008.10.052not held here
31ref31 A.R. Chang, C.M. Ferrer, R. Mostoslavsky, SIRT6, a Mammalian Deacylase with Multitasking Abilities, Physiol. Rev. 100 (2020) 145–16910.1152/physrev.00030.2018not held here
32ref32 Z. Li, K. Xu, N. Zhang, et al., Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling, Kidney Int 93 (2018) 881–89210.1016/j.kint.2017.10.021not held here
33ref33 V.I. Kuznetsov, W.H. Liu, M.A. Klein, et al., Potent Activation of NAD( +)- Dependent Deacetylase Sirt7 by Nucleosome Binding, ACS Chem. Biol. 17 (2022) 2248–226110.1021/acschembio.2c00348not held here
34ref34 S. Pande, S. Raisuddin, Molecular and cellular regulatory roles of sirtuin protein, Crit. Rev. Food Sci. Nutr. (2022) 1–1910.1080/10408398.2022.2070722not held here
35ref35 L. Li, L. Shi, S. Yang, et al., SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability, Nat. Commun. 7 (2016), 1223510.1038/ncomms12235not held here
36ref36 X. Bao, Z. Liu, W. Zhang, et al., Glutarylation of histone h4 lysine 91 regulates chromatin dynamics, e669, Mol. Cell 76 (2019) 660–67510.1016/j.molcel.2019.08.018not held here
37ref37 W. Stünkel, R.M. Campbell, Sirtuin 1 (SIRT1): the misunderstood HDAC, J. Biomol. Screen 16 (2011) 1153–116910.1177/1087057111422103not held here
38ref38 Y. Yao, W. Zhang, R. Ming, et al., Noninvasive 40-Hz light flicker rescues circadian behavior and abnormal lipid metabolism induced by acute ethanol exposure via improving SIRT1 a…10.3389/fphar.2020.00355not held here
39ref39 S. Venkatasubramanian, R.M. Noh, S. Daga, et al., Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers, J. Am. Heart Assoc. 2 (2013),…10.1161/jaha.113.000042not held here
40ref40 M. Kurano, K. Tsukamoto, T. Shimizu, et al., Apolipoprotein M/sphingosine 1- phosphate protects against diabetic nephropathy, Transl. Res (2023) 16–3410.1016/j.trsl.2023.02.004not held here
41ref41 Y. Fu, Y. Sun, M. Wang, et al., Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism, e1058, Cell Metab. 32 (2020) 1052–106210.1016/j.cmet.2020.10.019not held here
42ref42 L. Zhang, R. Tu, Y. Wang, et al., Early-Life exposure to lead induces cognitive impairment in elder mice targeting SIRT1 phosphorylation and oxidative alterations, Front Physiol. …10.3389/fphys.2017.00446not held here
43ref43 M. Eid, V. Dzreyan, S. Demyanenko, Sirtuins 1 and 2 in the acute period after photothrombotic stroke: expression, localization and involvement in apoptosis, Front Physiol. 13 (202…10.3389/fphys.2022.782684not held here
44ref44 T. Jiang, T. Qin, P. Gao, et al., SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc, Redox Biol. 60 (2023), 10261510.1016/j.redox.2023.102615not held here
45ref45 Y. Yu, X. Song, X. Wang, et al., Oxidative stress impairs the Nur77-Sirt1 axis resulting in a decline in organism homeostasis during aging, Aging Cell (2023), e1381210.1111/acel.13812not held here
46ref46 X. Song, F. Kong, Z. Zong, et al., miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1,…10.1039/c8ra09914fnot held here
47ref47 S.H. Dai, L.J. Chen, W.H. Qi, et al., microRNA-145 Inhibition Upregulates SIRT1 and Attenuates Autophagy in a Mouse Model of Lung Ischemia/ Reperfusion Injury via NF-κB-dependent …10.1097/tp.0000000000003435not held here
48ref48 W. Dong, H. Zhang, C. Zhao, et al., Silencing of miR-150-5p ameliorates diabetic nephropathy by targeting SIRT1/p53/AMPK Pathway, Front Physiol. 12 (2021), 62498910.3389/fphys.2021.624989not held here
49ref49 H.G. Zhang, F.J. Wang, Y. Wang, et al., lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback DOI:https://doi.org/10.46243/jst.2024…10.3892/or.2020.7825not held here
50ref50 Y. Xu, W. Wan, Acetylation in the regulation of autophagy, Autophagy 19 (2023) 379–38710.1080/15548627.2022.2062112not held here
51ref51 Y. Wang, R. Zhao, C. Wu, et al., Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling, Front Pharm. 14 (2023), 111132010.3389/fphar.2023.1111320not held here
52ref52 H.H. Chen, Y.X. Zhang, J.L. Lv, et al., Role of sirtuins in metabolic disease-related renal injury, Biomed. Pharm. 161 (2023), 11441710.1016/j.biopha.2023.114417not held here
53ref53 H. Kang, S. Kim, J.Y. Lee, et al., Inhibitory effects of ginsenoside compound K on lipopolysaccharidestimulated inflammatory responses in macrophages by regulating sirtuin 1 and h…10.3390/nu15071626not held here
54ref54 C. Sun, S. Bai, Y. Liang, et al., The role of Sirtuin 1 and its activators in age-related lung disease, Biomed. Pharm. 162 (2023), 11457310.1016/j.biopha.2023.114573not held here
55ref55 Miranda-Gonçalves, V. Lameirinhas, A. Macedo-Silva C, et al., Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition A…10.3390/cells9041053not held here
56ref56 X.J. Yu, X.Z. Guo, C. Li, et al., SIRT1-ZEB1positive feedback promotes epithelial- mesenchymal transition process and metastasis of osteosarcoma, J. Cell Biochem 120 (2019) 3727–3…10.1002/jcb.27653not held here
57ref57 A. Latifkar, L. Ling, A. Hingorani, et al., Loss of sirtuin 1 alters the secretome of breast cancer cells by impairing lysosomal integrity, e397, Dev. Cell 49 (2019) 393–40810.1016/j.devcel.2019.03.011not held here
58ref58 Y. Liang, X. Song, Y. Li, et al., A novel long noncoding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer, Cell Death Dis. 9 (2018), 56310.1038/s41419-018-0582-1not held here
59ref59 K. Rifaï, G. Judes, M. Idrissou, et al., SIRT1dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer, Oncotarget 9 (2018) 30661–3067810.18632/oncotarget.25771not held here
60ref60 A. Kuno, R. Hosoda, M. Tsukamoto, et al., SIRT1 in the cardiomyocyte counteracts doxorubicininduced cardiotoxicity via regulating histone H2AX, Cardiovasc Res 118 (2023) 3360–337310.1093/cvr/cvac026not held here
61ref61 M.S. Lee, Y. Kim, Chrysanthemum morifolium Flower Extract Inhibits Adipogenesis of 3T3-L1 Cells via AMPK/SIRT1 Pathway Activation, Nutrients 12 (2020) 272610.3390/nu12092726not held here
62ref62 M. Park, H. Baek, J.Y. Han, et al., Stevioside Enhances the Anti-Adipogenic Effect and β-Oxidation by Activating AMPK in 3T3-L1 Cells and Epididymal Adipose Tissues of db/db Mice,…10.3390/cells11071076not held here
63ref63 Z. Chai, Y. Yan, S. Zan, et al., Probioticfermented blueberry pomace alleviates obesity and hyperlipidemia in high-fat diet C57BL/6J mice, Food Res Int 157 (2022), 11139610.1016/j.foodres.2022.111396not held here
64ref64 J. Bai, T. Yang, Y. Zhou, et al., Octacosanol modifies obesity, expression profile and inflammation response of hepatic tissues in high-fat diet mice, Foods 11 (2022) 160610.3390/foods11111606not held here
65ref65 R.A. DeBose-Boyd, J. Ye, SREBPs in lipid metabolism, insulin signaling, and beyond, Trends Biochem Sci. 43 (2018) 358–36810.1016/j.tibs.2018.01.005not held here
66ref66 X. Hua, A. Nohturfft, J.L. Goldstein, et al., Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein, Cell 87 (1996) 415–42610.1016/s0092-8674(00)81362-8not held here
67ref67 J. Sakai, A. Nohturfft, D. Cheng, et al., Identification of complexes between the COOHterminal domains of sterol regulatory elementbinding proteins (SREBPs) and SREBP cleavageacti…10.1074/jbc.272.32.20213not held here
68ref68 A. Nohturfft, M.S. Brown, J.L. Goldstein, Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain, J. Biol. Chem. 273 (1998) 17243…10.1074/jbc.273.27.17243not held here
69ref69 X. Hua, J. Wu, J.L. Goldstein, et al., Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosom…10.1016/0888-7543(95)80009-bnot held here
70ref70 I. Shimomura, H. Shimano, J.D. Horton, et al., Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cu…10.1172/jci119247not held here
71ref71 D. Eberl´e, B. Hegarty, P. Bossard, et al., SREBP transcription factors: master regulators of lipid homeostasis, Biochimie 86 (2004) 839–848, M.S. Brown, J.L. Goldstein, The SREBP…10.1016/j.biochi.2004.09.018not held here
72ref72 H. Shimano, J.D. Horton, I. Shimomura, et al., Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured …10.1172/jci119248not held here
73ref73 J. Kotzka, B. Knebel, H. Avci, et al., Phosphorylation of sterol regulatory element- binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes, Ath…10.1016/j.atherosclerosis.2010.08.046not held here
74ref74 Y. An, D.D. Zhang, H.L. Yu, et al., 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells, Neurotoxicology 59 (2017) 88–9710.1016/j.neuro.2017.02.001not held here
75ref75 J.D. Horton, J.L. Goldstein, M.S. Brown, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest 109 (2002) 1125–113110.1172/jci0215593not held here
76ref76 M. Ruiz, R. Devkota, D. Panagaki, et al., Sphingosine 1-phosphate mediates adiponectin receptor signaling essential for lipid homeostasis and embryogenesis, Nat. Commun. 13 (2022)…10.1038/s41467-022-34931-0not held here
77ref77 W.J. Chen, W.K. Huang, S.R. Pather, et al., Podocalyxin-Like protein 1 regulates pluripotency through the cholesterol biosynthesis pathway, Adv. Sci. (Weinh.) 10 (2022), e220545110.1002/advs.202205451not held here
78ref78 V. Sengottuvel, M. Hota, J. Oh, et al., Deficiency in the omega-3 lysolipid transporter Mfsd2a leads to aberrant oligodendrocyte lineage development and hypomyelination, J. Clin. …10.1172/jci164118not held here
79ref79 R. Ganji, J.A. Paulo, Y. Xi, et al., The p97-UBXD8 complex regulates ER-Mitochondria contact sites by altering membrane lipid saturation and composition, Nat. Commun. 14 (2023), 6…10.1038/s41467-023-36298-2not held here
80ref80 J.Y. Kim, L.Q. Wang, V.C. Sladky, et al., PIDDosome-SCAP crosstalk controls high- fructosediet-dependent transition from simple steatosis to steatohepatitis, e1546, Cell Metab. 34…10.1016/j.cmet.2022.08.005not held here
81ref81 G. Li, H. Chen, F. Shen, et al., Targeting hepatic serine-arginine protein kinase 2 ameliorates alcoholassociated liver disease by alternative splicing control of lipogenesis, Hep…10.1097/hep.0000000000000433not held here
82ref82 X. Fang, J. Zhang, Y. Li, et al., Malic Enzyme 1 as a Novel Anti-Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury, Adv. Sci. (Weinh.) 10 (2023), e2205436, J.Q. Wang, L…10.1002/advs.202370079not held here
83ref83 D. Wu, Y. Yang, Y. Hou, et al., Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin …10.1002/cac2.12247not held here
84ref84 A. Husain, Y.T. Chiu, K.M. Sze, et al., Ephrin-A3/ EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma, J. Hepatol. 7…10.1016/j.jhep.2022.02.018not held here
85ref85 H.M. Lee, A. Nayak, J. Kim, A new role for ammonia in tumorigenesis, Cell Metab. 34 (2022) 944–94610.1016/j.cmet.2022.06.009not held here
86ref86 C. Cheng, F. Geng, Z. Li, et al., Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth, Nat. Metab. 4 (2022) 575–58810.1038/s42255-022-00568-ynot held here
87ref87 I. Mahmud, G. Tian, J. Wang, et al., DAXX drives de novo lipogenesis and contributes to tumorigenesis, Nat. Commun. 14 (2023), 192710.1038/s41467-023-37501-0not held here
88ref88 W. Dai, W. Xiang, L. Han, et al., PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism, Cancer Commun. (Lond.) 42 (2022) 848–86710.1002/cac2.12341not held here
89ref89 L. Xue, H. Qi, H. Zhang, et al., Targeting SREBP- 2-Regulated Mevalonate Metabolism for Cancer Therapy, Front Oncol. 10 (2020), 151010.3389/fonc.2020.01510not held here
90ref90 M. Arito, T. Horiba, S. Hachimura, et al., Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expres…10.1074/jbc.m800910200not held here
91ref91 P.F. Lebeau, J.H. Byun, K. Platko, et al., Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance, Nat. Commun. 13 (2022), 77010.1038/s41467-022-28240-9not held here
92ref92 Z. Lu, L. Huang, Y. Li, et al., Fine-tuning of cholesterol homeostasis controls erythroid differentiation, Adv. Sci. (Weinh.) 9 (2022), e210266910.1002/advs.202102669not held here
93ref93 J. Chen, H. Zhang, L. Li, et al., Lp-PLA(2) (Lipoprotein-associated phospholipase a (2)) deficiency lowers cholesterol levels and protects against atherosclerosis in rabbits, Arte…10.1161/atvbaha.122.317898not held here
94ref94 H. Liu, M. Hallauer Hastings, R. Kitchen, et al., Beneficial effects of moderate hepatic activin a expression on metabolic pathways, inflammation, and atherosclerosis, Arterioscle…10.1161/atvbaha.122.318138not held here
95ref95 H.M. Cheng, M. Xing, Y.P. Zhou, et al., HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling, Cell Death Differ. 30 (2023) 673–68610.1038/s41418-022-01071-3not held here
96ref96 W. Tang, J. Zhou, W. Yang, et al., Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver, Cell Mol…10.1038/s41423-022-00872-3not held here
97ref97 H. Zou, Y. Yang, Z. Shi, et al., Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin …10.1016/j.phrs.2022.106324not held here
98ref98 E. Branche, Y.T. Wang, K.M. Viramontes, et al., SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus, Nat. Commun. 13 (2022), 53…10.1038/s41467-022-33041-1not held here
99ref99 H. Shimano, J.D. Horton, R.E. Hammer, et al., Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a, J. C…10.1172/jci118951not held here
100ref100 W. Chen, L. Wen, Y. Bao, et al., Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and upregulating SREBP2, Proc. Natl. Acad. Sc…10.1073/pnas.2203894119not held here
101ref101 C. Zheng, Y. Zhu, Q. Liu, et al., Maprotiline suppresses cholesterol biosynthesis and hepatocellular carcinoma progression through direct targeting of CRABP1, Front Pharm. 12 (202…10.3389/fphar.2021.689767not held here
102ref102 Y.Y. Chen, J.Y. Ge, S.Y. Zhu, et al., Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis, Nat. Commun. 13 (20…10.1038/s41467-022-28452-znot held here

… and 81 more in the JSON.

The references as JSON

Relations

The record states no relation, and no record held here states one with this DOI.

The relations as JSON

Funding

The record names no funder.

Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.

History — the ledger

Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.

#WhenWhatByChanges
129 Sep 2026, 10:00 PMregister
registered at Crossref; record read from api.crossref.org
Administrator (admin) 610 fields set · sha256 fcf3491e3048…
229 Sep 2026, 11:59 PMupdate
record re-read from api.crossref.org
Administrator (admin)
container.titles.0.value: Journal of Science & Technology → Journal of Science & Technology

Machine-readable: the history as JSON, with the full record after each change.

Changes made at Crossref through DOI Doctor

Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.

WhenWhat changedCrossrefFingerprint
21 Sep 2026, 01:50Metadata completed
publication date
● accepted by Crossrefdfcd1dc1925b…
21 Sep 2026, 02:50Read back: Crossref's record shows it● confirmed6b5fcd8b74fb…

2 entries · the last fingerprint 6b5fcd8b74fb20f242ed5932c49b212f9b2a1b0bf010fd75145892c400ea0f8f · the history as JSON, each entry with the fingerprint before it, to check them yourself.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp